Merck to Complete Acquisition of Cidara Therapeutics
Go back to Merck to Complete Acquisition of Cidara Therapeutics| Fidelity Advisor Small Cap independence Fund Class T (NASDAQ: CDTX) | Delayed: 221.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $221.38 | 52 Week High | $18.07 | |||
| Open | $221.38 | 52 Week Low | $8.65 | |||
| Day High | $221.38 | P/E | N/A | |||
| Day Low | $221.38 | EPS | $0.00 | |||
| Volume | 229 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 130.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.76 | 52 Week High | $65.46 | |||
| Open | $130.76 | 52 Week Low | $47.97 | |||
| Day High | $130.76 | P/E | 88.95 | |||
| Day Low | $130.76 | EPS | $1.47 | |||
| Volume | 1,371 | |||||
